Alex Goldberg

ARCA Biopharma, Inc. (NASDAQ:ABIO) and eBay Inc. (NASDAQ:EBAY) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/10/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding ARCA biopharma, Inc. (NASDAQ:ABIO) and eBay Inc. (NASDAQ:EBAY).

ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company that focuses on developing genetically-targeted therapies for cardiovascular diseases is currently down (-3.40%) on 1,073,038 shares traded after ARCA biopharma Announced US FDA Acceptance of Gencaro Companion Diagnostic Test IDE. ARCA biopharma, Inc. (NASDAQ:ABIO) is currently down (-67.85%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about ARCA biopharma, Inc. (NASDAQ:ABIO)

eBay Inc. (NASDAQ:EBAY) a company that provides online platforms, tools, and services to help individuals and merchants in online and mobile commerce and payments in the United States and internationally is currently down (-1.15%) on 11,697,694 shares traded after eBay Enterprise announced the company has added 228 premier brands and retailers in 2013. eBay Inc. (NASDAQ:EBAY) is currently down (-11.94%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about eBay Inc. (NASDAQ:EBAY)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com